The health and pharmaceutical industry is one of three key industries in Zhongshan. On the morning of December 3, the Wuguishan District Office held a signing ceremony with Guangdong Dafan Medical Group Co Ltd for its settlement.

With an investment of approximately 400 million yuan, Dafan's settlement project will be based at Changmingshui Village, Wuguishan District, where it will cover an area of 30 mu (20,000 square meters). The project will come in two phases. About 250 million yuan will be utilized for the first phase (2020-2023), with an estimated output of 1.8 billion within three years.

The settlement project is planning to focus on the construction of domestic leading technology research laboratories. The National Medical Surgical Equipment Instruments and Materials Engineering and Technology Research Center will be established here as well.

Based on this platform, the project plans to form a technical research and development community together with relevant universities and scientific research institutions at home and abroad. It will also build a public-welfare and open cooperation research and development platform and an enterprise-school cooperation personnel training base in conjunction with local universities and colleges, such as the UESTC Zhongshan Institute and the Open University of Guangdong Zhongshan Campus.

Up to now, Dafan company has owned 15 independent intellectual property rights, and has obtained national invention patents on 4 achievements. These breakthrough devices include the self-developed spinal ablation electrode scalpel, electrocoagulation cutter, safe biopsy gun, and special ablation electrode for ear, nose and throat.